Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
    • Report a Problem
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
    • MIS Systems
    • Online Data Verification
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > Publications > Meeting Minutes > Clinical Studies Committee > Minutes of 51st Meeting of Clinical Studies Committee

Minutes of 51st Meeting of Clinical Studies Committee

Asad Ullah Clinical Studies Committee November 5, 2024November 7, 2024
51.-Minutes-of-the-51st-CSC-Meeting-24-10-2024-SummaryDownload

Share this:

  • Twitter
  • Facebook
  • ← Notification for GCP Inspections
  • Draft Guidance Document For Clinical Trials Of Biological Products (Manufacture Locally) →
  • Guidelines
    • Pharmaceuticals
    • Biologicals
    • Medical Devices
    • Alternative Medicines & Health Products
    • Pharmacy Services
    • Pharmacovigilance
    • Quality Assurance
  • Newsletters
  • Regulatory Procedures
  • Regulatory Fees
  • Application Forms
  • Public Consultations
    • Open Consultations
    • Closed Consultations
    • How to Submit Comments
  • Minutes of the Meetings
    • Registration Board
    • Central Licensing Board
    • Medical Devices Board
    • Enlistment Evaluation Committee
    • Clinical Studies Committee
    • Pharmacovigilance RAE Committee

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem